Cite
MLA Citation
Katherine Peters et al.. “ATIM-31. SAFETY OF TUMOR-SPECIFIC PEPTIDE VACCINE TARGETING ISOCITRATE DEHYDROGENASE 1 MUTATION IN RECURRENT RESECTABLE LOW GRADE GLIOMA PATIENTS.” Neuro-oncology, vol. 21, n.d., p. vi8. http://access.bl.uk/ark:/81055/vdc_100101668443.0x00004e